Economic evaluation in stroke research: a systematic review

SMAA Evers, AJHA Ament, G Blaauw - Stroke, 2000 - Am Heart Assoc
Economic Evaluation Designs This systematic review concentrates on full economic evaluation
studies. A full economic evaluation study must compare 2 or more program alternatives, …

[HTML][HTML] Health economic evaluations of digital health interventions for secondary prevention in stroke patients: a systematic review

A Valenzuela Espinoza, S Steurbaut… - Cerebrovascular …, 2019 - karger.com
… lack of clear economic incentives for implementation. We propose to map all health economic
evidence regarding digital health interventions for secondary stroke prevention. Summary: …

Approaches to economic evaluations of stroke rehabilitation

LE Craig, O Wu, J Bernhardt… - … Journal of Stroke, 2014 - journals.sagepub.com
… This review included 21 studies that had conducted an economic evaluation of a stroke
, ie, preventing an evaluation proceeding to a full trial that is unlikely to be cost-effective. …

Cost-effectiveness of stroke treatments and secondary preventions

F Pan, L Hernandez, A Ward - Expert opinion on pharmacotherapy, 2012 - Taylor & Francis
economic evaluation of stroke treatments and prevention strategies. … prevention of stroke,
are not included in this review. A comprehensive electronic search for economic evaluations in …

Economic evaluation in stroke research: an introduction

SMAA Evers, MEJB Goossens, AJHA Ament… - Cerebrovascular …, 2001 - karger.com
… of stroke, the so-called Stroke Prevention Policy Model (SPPM) [29, 30]. The SPPM incorporates
component models for the natural history of stroke, implication of prevention strategies, …

Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation

SM Singh, A Micieli, HC Wijeysundera - Circulation, 2013 - Am Heart Assoc
… In conclusion, we found that novel stroke prevention strategies are cost-effective compared
with warfarin therapy in patients at risk for stoke because of NVAF, with a strategy of LAA …

[HTML][HTML] The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation …

MG Cherry, J Greenhalgh, L Osipenko… - Health technology …, 2012 - ncbi.nlm.nih.gov
… at the highest risk of stroke. A number of primary stroke prevention strategies are currently
used … of primary stroke prevention strategies in children with SCD identified to be at high risk of …

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic …

R Noviyani, S Youngkong, S Nathisuwan… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
… Our findings confirm the individual economic evaluations in UMICs that all DOACs were less
… Many of the economic evaluations of DOACs versus VKAs for stroke prevention in patients …

[HTML][HTML] Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation

T Wisløff, G Hagen, M Klemp - Pharmacoeconomics, 2014 - Springer
… As mentioned in the Introduction, we have only been able to find two economic evaluations
comparing all NOACs in one analysis, as we do here. The results of these analyses were …

Improving economic evaluations in stroke: a report from the ESO Health Economics Working Group

…, ESO Health Economics Working group - European Stroke …, 2020 - journals.sagepub.com
… Therefore, with the growing number of interventions becoming available to prevent or
treat stroke, it is important to standardise and improve the methods for conducting cost-…